Total Payments
$2.0M
2024 Payments
$411,634
Companies
25
Transactions
2,951
Medicare Patients
27
Medicare Billing
$16,596
Payment Breakdown by Category
Other$1.6M (79.2%)
Travel$300,139 (14.8%)
Consulting$76,681 (3.8%)
Food & Beverage$43,817 (2.2%)
Education$168.88 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1.6M | 851 | 78.4% |
| Travel and Lodging | $300,139 | 790 | 14.8% |
| Consulting Fee | $76,681 | 35 | 3.8% |
| Food and Beverage | $43,817 | 1,259 | 2.2% |
| Honoraria | $15,300 | 8 | 0.8% |
| Education | $168.88 | 8 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $553,228 | 646 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $390,237 | 434 | $0 (2024) |
| Allergan, Inc. | $225,626 | 412 | $0 (2021) |
| ITI, Inc. | $201,091 | 191 | $0 (2023) |
| Takeda Pharmaceuticals U.S.A., Inc. | $163,720 | 181 | $0 (2022) |
| Takeda Pharmaceuticals America, Inc. | $123,554 | 150 | $0 (2017) |
| Axsome Therapeutics, Inc. | $80,613 | 83 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $70,376 | 87 | $0 (2024) |
| Neos Therapeutics, LP | $60,385 | 201 | $0 (2022) |
| Ironshore Pharmaceuticals Inc. | $57,918 | 104 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $411,634 | 481 | ABBVIE INC. ($153,470) |
| 2023 | $408,796 | 434 | AbbVie Inc. ($153,935) |
| 2022 | $307,202 | 385 | ABBVIE INC. ($145,523) |
| 2021 | $197,826 | 317 | AbbVie Inc. ($100,300) |
| 2020 | $127,466 | 203 | Allergan, Inc. ($80,828) |
| 2019 | $134,212 | 295 | Allergan Inc. ($77,080) |
| 2018 | $240,896 | 445 | Takeda Pharmaceuticals U.S.A., Inc. ($129,418) |
| 2017 | $195,412 | 391 | Takeda Pharmaceuticals America, Inc. ($123,554) |
All Payment Transactions
2,951 individual payment records from CMS Open Payments — Page 1 of 119
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/19/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $12.66 | General |
| Category: PSYCHIATRY | ||||||
| 12/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.20 | General |
| Category: NEUROSCIENCE | ||||||
| 12/18/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $30.35 | General |
| Category: ADHD | ||||||
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $79.54 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $25.73 | General |
| Category: Neuroscience | ||||||
| 12/13/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $353.46 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Travel and Lodging | In-kind items and services | $273.00 | General |
| Category: Neuroscience | ||||||
| 12/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,250.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Travel and Lodging | Cash or cash equivalent | $950.84 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/11/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | Cash or cash equivalent | $125.00 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/06/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $4.99 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $738.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $385.96 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $96.15 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $34.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Axsome Therapeutics, Inc. | Auvelity (Drug) | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: Psychology/Psychiatric | ||||||
| 12/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $28.79 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | ABBVIE INC. | VRAYLAR (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,975.00 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 27 | 338 | $36,570 | $16,596 |
Total Patients
27
Total Services
338
Medicare Billing
$16,596
Procedure Codes
2
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 14 | 70 | $23,170 | $9,805 | 42.3% |
| G2212 | Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | Office | 2023 | 13 | 268 | $13,400 | $6,791 | 50.7% |
About Dr. John Vaeth, MD
Dr. John Vaeth, MD is a Psychiatry healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/15/2007. The National Provider Identifier (NPI) number assigned to this provider is 1992848345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Vaeth, MD has received a total of $2.0M in payments from pharmaceutical and medical device companies, with $411,634 received in 2024. These payments were reported across 2,951 transactions from 25 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($1.6M).
As a Medicare-enrolled provider, Vaeth has provided services to 27 Medicare beneficiaries, totaling 338 services with total Medicare billing of $16,596. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Baltimore, MD
- Active Since 02/15/2007
- Last Updated 07/08/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1992848345
Products in Payments
- VRAYLAR (Drug) $778,779
- REXULTI (Drug) $391,592
- CAPLYTA (Drug) $271,468
- Trintellix (Drug) $268,298
- Auvelity (Drug) $80,613
- Adzenys XR-ODT (Drug) $60,289
- JORNAY PM (Drug) $57,918
- FANAPT (Drug) $47,049
- MYDAYIS (Drug) $13,554
- VYVANSE (Drug) $12,684
- Quillichew ER (Drug) $9,138
- Dyanavel XR (Drug) $7,459
- QELBREE (Drug) $6,042
- Vyvanse (Drug) $5,366
- SPRAVATO (Drug) $1,407
- TRINTELLIX (Drug) $1,396
- ZolpiMist (Drug) $950.00
- Evekeo (Drug) $258.21
- Quillivant (Drug) $246.22
- Entyvio (Biological) $196.20
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Baltimore
Scott Aaronson, M.d, M.D
Psychiatry — Payments: $414,719
Psychiatry $414,719
Dr. Robert Lehman, M.d, M.D
Psychiatry — Payments: $210,729
Psychiatry $210,729
Paul Rosenberg, M.d, M.D
Psychiatry — Payments: $162,959
Psychiatry $162,959
Dr. Karen Anderson, M.d, M.D
Psychiatry — Payments: $158,684
Psychiatry $158,684
Orlando Davis, M.d, M.D
Psychiatry — Payments: $131,372
Psychiatry $131,372
Prof. Akira Sawa, M.d, M.D
Psychiatry — Payments: $88,697
Psychiatry $88,697